Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer's disease model.
- DOI
- 10.1016/j.ejmech.2026.118670
- Published
- 2026 Apr 5
- Container
- European journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2026.118670,
title = {Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer's disease model.},
author = {Travers-Lesage V and Crouzier L and Antonijevic M and Wang A and Toublet FX and Davis A and Modeste F and Brazzolotto X and Nachon F and Since M and Maurice T and Rochais C and Dallemagne P},
year = {2026},
journal = {European journal of medicinal chemistry},
doi = {10.1016/j.ejmech.2026.118670},
url = {https://doi.org/10.1016/j.ejmech.2026.118670}
}RIS
TY - JOUR TI - Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer's disease model. AU - Travers-Lesage V AU - Crouzier L AU - Antonijevic M AU - Wang A AU - Toublet FX AU - Davis A AU - Modeste F AU - Brazzolotto X AU - Nachon F AU - Since M AU - Maurice T AU - Rochais C AU - Dallemagne P PY - 2026 JO - European journal of medicinal chemistry DO - 10.1016/j.ejmech.2026.118670 UR - https://doi.org/10.1016/j.ejmech.2026.118670 ER -
APA
V, T., L, C., M, A., A, W., FX, T., A, D., F, M., X, B., F, N., M, S., T, M., C, R., & P, D. (2026). Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer's disease model.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2026.118670
Source records
- pubmed · retrieved 2026-09-25T22:45:04.042Z